These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17900229)

  • 1. Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pig.
    Tammewar AM; Cheng L; Hostetler KY; Falkenstein I; Beadle JR; Barron EC; Kozak I; Freeman WR
    J Ocul Pharmacol Ther; 2007 Oct; 23(5):433-44. PubMed ID: 17900229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular properties of hexadecyloxypropyl-cyclic-cidofovir in Guinea pigs.
    Lu S; Cheng L; Hostetler KY; Koh HJ; Beadle JR; Davidson MC; Freeman WR
    J Ocul Pharmacol Ther; 2005 Jun; 21(3):205-9. PubMed ID: 15969637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.
    Cheng L; Hostetler KY; Lee J; Koh HJ; Beadle JR; Bessho K; Toyoguchi M; Aldern K; Bovet JM; Freeman WR
    Invest Ophthalmol Vis Sci; 2004 Nov; 45(11):4138-44. PubMed ID: 15505067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of intravitreal injections of HPMPC and related nucleoside analogues on intraocular pressure in guinea pig eyes.
    Banker AS; De Clercq E; Taskintuna I; Keefe KS; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1233-42. PubMed ID: 9620084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1-O-hexadecylpropanediol-3-phospho-ganciclovir.
    Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Toyoguchi M; Bergeron-Lynn G; Freeman WR
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):515-21. PubMed ID: 11818399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Wiley CA; Freeman WR
    Invest Ophthalmol Vis Sci; 1999 Jun; 40(7):1487-95. PubMed ID: 10359331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal crystalline drug delivery for intraocular proliferation diseases.
    Cheng L; Hostetler K; Valiaeva N; Tammewar A; Freeman WR; Beadle J; Bartsch DU; Aldern K; Falkenstein I
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):474-81. PubMed ID: 19696179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel cytarabine crystalline lipid prodrug: hexadecyloxypropyl cytarabine 3',5'-cyclic monophosphate for proliferative vitreoretinopathy.
    Kim JS; Beadle JR; Freeman WR; Hostetler KY; Hartmann K; Valiaeva N; Kozak I; Conner L; Trahan J; Aldern KA; Cheng L
    Mol Vis; 2012; 18():1907-17. PubMed ID: 22876115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of retinal toxicity and liposome encapsulation of the anti-CMV drug 2'-nor-cyclic GMP.
    Shakiba S; Assil KK; Listhaus AD; Munguia D; Flores-Aguilar M; Vuong C; Wiley CA; Tolman RL; Karkas JD; Bergeron-Lynn G
    Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2903-10. PubMed ID: 8395482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular safety and pharmacokinetics of hexadecyloxypropyl-cidofovir (HDP-CDV) as a long-lasting intravitreal antiviral drug.
    Wang H; Chhablani J; Freeman WR; Beadle JR; Hostetler KY; Hartmann K; Conner L; Aldern KA; Pearson L; Cheng L
    Invest Ophthalmol Vis Sci; 2011 Dec; 52(13):9391-6. PubMed ID: 22058340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal toxicology and therapeutic efficacy of the carboxymethyl ester of the 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA-O-Me), a novel lipid antiviral prodrug for intraocular drug delivery.
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Keefe KS; Beadle JR; Wiley CA; Freeman WR
    J Ocul Pharmacol Ther; 1999 Aug; 15(4):363-77. PubMed ID: 10463875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Etoposide as a virocidal anticytomegalovirus therapy: intravitreal toxicology and pharmacology in rabbits.
    Morlet N; Stayt J; Vaegan ; Salonikas C; Naidoo D; Crouch R; Graham G; Coroneo M
    Aust N Z J Ophthalmol; 1999 Oct; 27(5):342-9. PubMed ID: 10571395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular toxicity of intravitreal tacrolimus.
    Passos E; Genaidy MM; Peyman GA
    Ophthalmic Surg Lasers; 2002; 33(2):140-4. PubMed ID: 11942546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of intravitreally injected povidone-iodine on Staphylococcus epidermidis in rabbit eyes.
    Trost LW; Kivilcim M; Peyman GA; Aydin E; Kazi AA
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):70-7. PubMed ID: 17341154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of vitreous clearance and potential retinal toxicity of intravitreal lornoxicam (xefo).
    Diakonis VF; Tsourdou A; Tzatzarakis MN; Tsika C; Charisis S; Naoumidi I; Plainis S; Tsilimbaris MK
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):627-32. PubMed ID: 23556534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of retinal toxicity of the anticytomegalovirus drug (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine.
    Dolnak DR; Munguia D; Wiley CA; De Clercq E; Bergeron-Lynn GL; Boscher C; Connor JD; Sherwood C; Capparelli E; Armani R
    Invest Ophthalmol Vis Sci; 1992 Apr; 33(5):1557-63. PubMed ID: 1559752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Micelle formulation of hexadecyloxypropyl-cidofovir (HDP-CDV) as an intravitreal long-lasting delivery system.
    Ma F; Nan K; Lee S; Beadle JR; Hou H; Freeman WR; Hostetler KY; Cheng L
    Eur J Pharm Biopharm; 2015 Jan; 89():271-9. PubMed ID: 25513956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit.
    Dvorchik BH; Marquis JK
    Drug Metab Dispos; 2000 Oct; 28(10):1255-61. PubMed ID: 10997948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.